Johnny Stilou

Johnny Stilou serves as the Chief Financial Officer at Saniona since May 2025, where the focus is on developing innovative treatments for neurological and psychiatric conditions. Prior to this role, Johnny held the position of Executive Vice President and CFO at Scandion Oncology, overseeing the development of novel oral drugs for cancer therapy. With a strong background in financial leadership, Johnny has also served as CFO at Amgen, where the acquisition of Nuevolution AB occurred, as well as at Fritz Schur Technical Group and Veloxis Pharmaceuticals. Early career experience includes roles at Silicon Labs, NetTest, GN Store Nord, and KPMG as a Senior Auditor. Johnny holds an Executive Management Program degree from INSEAD and a Master of Science in Business Economics and Auditing from Copenhagen Business School.